Cipherome

Pre-clinical

San Diego, United StatesFounded 2015cipherome.com

Founded in 2015 in Silicon Valley, Cipherome aims to accelerate precision medicine by simplifying complex healthcare data analysis. The company has evolved from a pharmacogenomics focus to offering the COMPASS platform, a comprehensive tool for clinical research, genomic analysis, and AI model training. Cipherome has conducted clinical validation studies with prestigious institutions and is actively commercializing its platform while contributing to healthcare data science education.

Founded

2015

Focus

DiagnosticsGenetics & Genomics

AI Company Overview

Technology Platform

COMPASS is a zero-code, end-to-end data analysis platform that enables extraction, cleaning, visualization, statistical testing, and AI model training on integrated clinical and genomic data without requiring programming skills.

Funding History

Total raised: $24M

Series A$20MUndisclosedAug 15, 2022

Seed$4MUndisclosedMay 15, 2020

Opportunities

Cipherome addresses the massive need to democratize analysis of the growing volume of clinical and genomic data.

Its no-code platform can capture market share from researchers lacking coding skills, while its pharmacogenomic algorithm has potential in the expanding precision medicine market.

Partnerships with biobanks and academic institutions provide a strong foundation for growth.

Risk Factors

Key risks include convincing researchers to adopt a new platform over flexible coding tools, potential regulatory hurdles if the DSS algorithm is used clinically, the challenges of data security and privacy, and the need for continued funding to achieve scale and profitability in a competitive market.

Competitive Landscape

Cipherome competes with traditional coding tools (Python/R), clinical analytics platforms (e.g., Tempus, Flatiron), and genomic analysis suites (e.g., DNAnexus). Its differentiation lies in its combined no-code interface, integrated clinical-genomic data handling, and foundation in validated pharmacogenomic science.